Use of Sodium–Glucose Cotransporter 2 (SGLT-2) Inhibitors Beyond Diabetes: On the Verge of a Paradigm Shift?. Rhythmos, [S. l.], v. 15, n. 1, p. 1–5, 2020. Disponível em: https://www.rhythmos.gr/index.php/Rhythmos/article/view/473. Acesso em: 3 may. 2025.